focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThalassa (di) Regulatory News (THAL)

Share Price Information for Thalassa (di) (THAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 26.00
Bid: 25.00
Ask: 27.00
Change: 0.50 (1.96%)
Spread: 2.00 (8.00%)
Open: 25.50
High: 26.00
Low: 25.50
Prev. Close: 25.50
THAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 8.3- NeutraHealth Plc

3 Jul 2009 15:43

RNS Number : 1213V
Thalassa Holdings Limited
03 July 2009
 



"DELAYED DISCLOSURE"

FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE

(Rule 8.3 of the City Code on Takeovers and Mergers)

 

1. KEY INFORMATION

Name of person dealing (Note 1)

Thalassa Holdings Ltd

Company dealt in

NeutraHealth Plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

ORD

Date of dealing

4 June 2009

 

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

 

(a)

Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

 

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities 

2,250,000

1.28%

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

2,250,000

1.28%

 

(b)

Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 Class of relevant security:

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

 

(c) Rights to subscribe (Note 3)

 

Class of relevant security:

Details

3. DEALINGS (Note 4)

 

(a) Purchases and sales

 

Purchase/sale 

Number of securities

Price per unit (Note 5)

PURCHASE

100,000

3.5p

 

(b) Derivatives transactions (other than options)

 

Product name,

e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

 

Product

name, e.g.

call option 

Writing,

selling,

purchasing,

varying etc.

Number of

securities to

which the

option

relates

(Note 7)

Exercise

price 

Type, e.g.

American,

European

etc.

Expiry

date

Option

money

paid/received

per unit (Note

5) 

 

 

(ii) Exercising

 

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 5)

 

(d) Other dealings (including new securities) (Note 4)

 

Nature of transaction (Note 8) 

Details

Price per unit (if applicable) (Note 5)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)

NO

 

Date of disclosure

3 July 2009

Contact name

Duncan Soukup

Telephone number

+33 678 632 689

If a connected EFM, name of offeree/offeror with which connected

If a connected EFM, state nature of connection (Note 10)

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETSSEFLDSUSELW
Date   Source Headline
30th Apr 20243:40 pmEQSThalassa Holdings Ltd:
30th Apr 20243:33 pmEQSThalassa Holdings Ltd: Annual Financial Report
12th Jan 20247:36 amEQSThalassa Holdings Ltd: Trading Update
16th Nov 202312:27 pmEQSThalassa Holdings Ltd: TR1
29th Sep 20239:01 amEQSThalassa Holdings Ltd: Interim Results (30 June 2023)
28th Sep 202311:09 pmEQSThalassa Holdings Ltd: Amendment to Articles of Association
17th Jul 20238:12 amEQSThalassa Holdings Ltd: Restoration of Listing
10th Jul 202310:50 amEQSThalassa Holdings Ltd: Final Results For Year Ended 31 December 2022
30th Jun 20237:57 pmEQSThalassa Holdings Ltd: Result of AGM
7th Jun 20237:51 pmEQSThalassa Holdings Ltd: AGM Proxy Form
5th Jun 202311:20 amEQSThalassa Holdings Ltd: Notice of AGM
2nd May 20237:51 amEQSThalassa Holdings Ltd: Temporary Suspension
2nd May 20237:30 amRNSSuspension - Thalassa Holdings Ltd
19th Apr 20238:45 pmEQSAppointment of Auditor
14th Feb 20234:12 pmEQSThalassa Holdings Ltd: Confirmation of previously announced proposal
27th Jan 20233:40 pmEQSThalassa Holdings Ltd: Trading Statement
27th Jan 20232:40 pmEQSThalassa Holdings Ltd: Trading Statement
13th Dec 20227:38 pmEQSThalassa Holdings Ltd: STR-Statement re resignation of auditor
13th Dec 20226:38 pmEQSThalassa Holdings Ltd: STR-Statement re resignation of auditor
24th Oct 20228:35 amEQSThalassa Holdings Ltd: Correction
24th Oct 20228:34 amEQSThalassa Holdings Ltd: Correction
21st Oct 202211:00 amEQSThalassa Holdings Ltd: Directorate Change
21st Oct 202210:59 amEQSThalassa Holdings Ltd: Directorate Change
15th Aug 20227:01 amEQSThalassa Holdings Ltd: Interim Results
15th Aug 20227:00 amEQSThalassa Holdings Ltd: Interim Results
28th Jun 20223:47 pmEQSThalassa Holdings Ltd: Result of AGM
28th Jun 20223:47 pmEQSThalassa Holdings Ltd: Result of AGM
27th Jun 20221:03 pmEQSThalassa Holdings Ltd: Appointment of Broker
27th Jun 20221:02 pmEQSThalassa Holdings Ltd: Appointment of Broker
9th Jun 20223:37 pmEQSThalassa Holdings Ltd: Final Results for Year Ended 31 December 2021
9th Jun 20223:34 pmEQSThalassa Holdings Ltd: Final Results for Year Ended 31 December 2021
9th Jun 20223:19 pmEQSThalassa Holdings Ltd: Notice of AGM
9th Jun 20223:18 pmEQSThalassa Holdings Ltd: Notice of AGM
24th May 202211:27 amEQSThalassa Holdings Ltd: Appointment of Non-Executive Director
28th Feb 20221:37 pmEQSThalassa Holdings Ltd: Trading Statement
17th Dec 20217:17 amRNSReverse Takeover of id4 AG by Anemoi International
15th Nov 20219:01 amRNSid4 delivers Client Space solution
28th Oct 20215:00 pmRNSHolding(s) in Company
7th Oct 20213:59 pmRNSResult of AGM
28th Sep 20217:00 amRNSInterim Results
17th Sep 202112:50 pmRNSLondon Medical Laboratory investment update
30th Jul 20213:23 pmRNSProposed Transaction
22nd Jun 202110:29 amRNSFinal Results for YE 31 Dec 2020 and Notice of AGM
14th Jun 20217:00 amRNSPreliminary Results for the year ended 31 Dec 20
29th Apr 20217:01 amRNSGrant Funded Project for Autonomous Robotics Ltd
29th Apr 20217:00 amRNSNotice of Results
8th Mar 20217:00 amRNSDe-listing from Luxembourg Stock Exchange
3rd Mar 20217:00 amRNSAppointment of Chief Financial Officer
4th Feb 202111:17 amRNSThalassa subsidiary id4 wins at Swiss WB Awards
2nd Feb 20217:00 amRNSInvestment in London Medical Laboratory Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.